Drug application
FENTANYL (FENTANYL CITRATE)
Drugs@FDA NDA 020195 · CEPHALON
Key facts
| Drug name | FENTANYL |
|---|---|
| Active ingredients | FENTANYL CITRATE |
| Application type | NDA |
| Application number | 020195 |
| Company | CEPHALON |
| Dosage forms | TROCHE/LOZENGE, ORAL |
| Strength | EQ 0.2MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Oct 4, 1993 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: